The role of a disturbed arginine/NO metabolism in the onset of cancer cachexia: a working hypothesis.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic hypothesis paper with no primary human data.
PubMed 22963622 · doi:10.2174/092986712803833290
What was done
This is a narrative review presenting a mechanistic working hypothesis. The authors synthesized existing literature on tumor-host immune interactions, myeloid-derived suppressor cell (MDSC) recruitment, and arginine/nitric oxide (NO) pathway alterations to explain the onset of muscle wasting in cancer cachexia.
What was found
The abstract reports a conceptual model and presents no quantitative data, statistics, or experimental numbers. It outlines a proposed pathway where tumors recruit MDSCs that deplete arginine and perturb NO production; the body attempts to compensate by mobilizing glutamine and arginine from skeletal muscle, activating pathways that suppress protein synthesis and promote proteolysis.
Why it matters
It offers a unifying metabolic and immunological hypothesis linking tumor immune-evasion mechanisms directly to systemic muscle catabolism, highlighting potential targets for future therapeutic trials.
Limits
The paper presents a theoretical framework without primary experimental or clinical data. The proposed mechanisms require prospective empirical and interventional testing to establish causality.
Cited by
- context Cancer cachexia occurs when tumor cells mobilize and consume glutamine by breaking down host skeletal muscle.